XML 17 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 204,368 $ 83,679
Accounts receivable, net 4,202 4,061
Inventory 38  
Prepaid expenses and other current assets 5,604 2,159
Total current assets 214,212 89,899
Property, plant and equipment, net 7,784 4,480
Operating lease right-of-use assets, net 1,371 1,704
Indemnification asset, related party 7,206 6,707
Contract acquisition costs, net 7,433 7,922
Intangible asset, net 3,219 3,430
Goodwill 3,903 3,903
Other assets 7,758 287
Total assets 252,886 118,332
Current liabilities:    
Accounts payable 2,298 1,396
Accrued expenses and other current liabilities 17,039 13,400
Revenue interest financing payable, current 13,252 2,615
Operating and finance lease liabilities, current 1,249 1,139
Total current liabilities 33,838 18,550
Litigation finance payable 7,196 6,707
Revenue interest financing payable, noncurrent 99,892 43,418
Operating and finance lease liabilities, noncurrent 1,442 2,364
Total liabilities 142,368 71,039
Commitments and contingencies (Note 13)
Stockholders' equity:    
Preferred stock - 10,000,000 shares authorized, none outstanding 0 0
Common stock - $0.001 par value, 115,000,000 and 100,000,000 shares authorized as of September 30, 2024 and December 31, 2023, respectively, 84,545,409 and 68,629,575 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively 85 69
Additional paid-in capital 631,556 476,322
Accumulated deficit (521,123) (429,098)
Total stockholders' equity 110,518 47,293
Total liabilities and stockholders' equity $ 252,886 $ 118,332